Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) covers the period ending November 27, 2013. The report details a specific corporate action regarding the repurchase of the company's own ordinary shares under authority granted by shareholders at the Annual General Meeting on May 1, 2013.
Key Financial Metrics
The filing does not provide data on revenue, profit, cash flow, margins, debt, or liquidity. It focuses exclusively on share repurchase activity and capital structure metrics:
- Shares Purchased: 865,000 Ordinary Shares of 25 pence each.
- Purchase Price Range: Highest price paid was 1,623.00 pence per share; lowest price paid was 1,612.00 pence per share.
- Treasury Holdings (Settled): 509,932,909 shares, representing 9.49% of total issued share capital.
- Treasury Holdings (Including Unsettled): 510,797,909 shares, representing 10.51% of total voting rights.
- Shares in Issue (Excluding Treasury): 4,861,740,586 shares.
Material Changes
The material change reported is the reduction of outstanding shares through the purchase of 865,000 shares on November 27, 2013. These shares are intended to be held in Treasury. Consequently, the total number of shares held in Treasury increased to approximately 510.8 million (including unsettled transactions), increasing the proportion of total voting rights held in Treasury to 10.51%.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It is a compliance announcement confirming conformity with the Financial Conduct Authority's Disclosure and Transparency Rules and explicitly states it does not constitute an offer or solicitation to purchase securities.
Investor Verification Checklist
- Verify the total number of shares in issue (4,861,740,586) for calculating ownership thresholds under Disclosure and Transparency Rules.
- Confirm the current percentage of voting rights held in Treasury (10.51% including unsettled shares).
- Review the price range paid (1,612.00 to 1,623.00 pence) against market prices on November 27, 2013.
- Note that this filing does not contain operational or financial performance data for the period.